BiotechTube

Fycompa

Pre-clinicalCompleted
2 views this week 0 watching💤 Quiet
Interest: 26/100
26
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Partial Seizures (With or Without Secondary Generalized Seizures)

Conditions

Partial Seizures (With or Without Secondary Generalized Seizures), Primary Generalized Tonic-clonic Seizures

Trial Timeline

Aug 1, 2016 → Mar 21, 2021

NCT ID
NCT03059381

About Fycompa

Fycompa is a pre-clinical stage product being developed by Eisai for Partial Seizures (With or Without Secondary Generalized Seizures). The current trial status is completed. This product is registered under clinical trial identifier NCT03059381. Target conditions include Partial Seizures (With or Without Secondary Generalized Seizures), Primary Generalized Tonic-clonic Seizures.

What happened to similar drugs?

18 of 20 similar drugs in Partial Seizures (With or Without Secondary Generalized Seizures) were approved

Approved (18) Terminated (5) Active (2)
✅Perampanel + PlaceboEisaiApproved
✅Adjunctive Zonisamide + Replacement with ZonisamideEisaiApproved
✅PerampanelEisaiApproved
✅Eslicarbazepine acetate + Eslicarbazepine AcetateSumitomo PharmaApproved
✅OxcarbazepineNovartisApproved
✅OxcarbazepineNovartisApproved
✅Hydrocortisone + PlaceboNovo NordiskApproved

Hype Score Breakdown

Clinical
3
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT03208660Pre-clinicalCompleted
NCT03059381Pre-clinicalCompleted
NCT03059329Pre-clinicalCompleted

Competing Products

20 competing products in Partial Seizures (With or Without Secondary Generalized Seizures)

See all competitors
ProductCompanyStageHype Score
E2007EisaiPhase 3
40
PerampanelEisaiPre-clinical
26
perampanel + perampanelEisaiPhase 1
29
perampanel + perampanel + perampanel + PlaceboEisaiPhase 3
40
Perampanel + PlaceboEisaiApproved
35
Perampanel and Microgynon-30 + Perampanel and Microgynon-30EisaiPhase 1
29
perampanelEisaiPhase 2
35
PerampanelEisaiPre-clinical
26
Zonisamide + PlaceboEisaiPhase 3
40
zonisamideEisaiPre-clinical
26
E2007 (perampanel) + E2007 (perampanel) + PlaceboEisaiPhase 3
40
Perampanel + PlaceboEisaiPhase 3
40
E2007 (perampanel) + E2007 (perampanel) + PlaceboEisaiPhase 3
40
Adjunctive Zonisamide + Replacement with ZonisamideEisaiApproved
43
Zonisamide + PlaceboEisaiPhase 3
40
FycompaEisaiPre-clinical
26
RufinamideEisaiPhase 3
32
ZonisamideEisaiPhase 3
40
Eslicarbazepine Acetate tabletsEisaiPre-clinical
26
PerampanelEisaiPre-clinical
26